Kennedy-Gingrich Anti-Opioid Group Funded By Maker Of Opioid Addiction Medication

Posted on March 4, 2018 by Pharmaciststeve

Kennedy-Gingrich Anti-Opioid Group Funded By Maker Of Opioid Addiction Medication

https://khn.org/morning-breakout/kennedy-gingrich-anti-opioid-group-funded-by-maker-of-opioid-addiction-medication/

Braeburn Pharmaceuticals, which won approval last year to market an implant that continuously dispenses the opioid addiction medicine buprenorphine, entered into an agreement to make a $900,000 charitable donation to Advocates for Opioid Recovery. Media outlets report on the crisis out of California, Ohio, Pennsylvania, Missouri, New Hampshire and Massachusetts as well.

Stat: Mystery Solved: Addiction Medicine Maker Is Secret Funder Of Kennedy-Gingrich Group A company that sells a new opioid-addiction medication is a secret funder of an advocacy group fronted by Newt Gingrich and Patrick Kennedy that is pushing for more government funding and insurance coverage of such treatments. Gingrich, the former Republican House speaker and a Trump confidant, and Kennedy, a former congressman and son of former US Senator Edward Kennedy, are paid advisors to Advocates for Opioid Recovery. They have generated a flurry of media attention in those roles, including joint interviews with outlets ranging from Fox News to the New Yorker. (Armstrong, 3/3)

Filed under: General Problems

« »

5 Responses

  1. Plow, on March 5, 2018 at 5:58 pm said:

    FOLLOW THE MONEY!!!! Legalize cannabis!!! Oh, I forgot!! This is the cash cow for the police!

    Reply
  2. Roni, on March 5, 2018 at 4:26 pm said:

    Why would you need an implant that continuously dispenses addiction meds?

    Reply
  3. maryw M, on March 5, 2018 at 8:04 am said:

    Do u know how many human beings they have killed!!!!!!!!!!MARY

    Reply
  4. connie, on March 5, 2018 at 12:32 am said:

    Surprise, surprise! Once again follow the money!!

    Reply

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading